Antibacterial and Antibiofilm Potential of Thymol–Benzimidazolium–Chalcone Hybrids Against Clinical MRSA Strains: Insights from Gene Expression Profiling and Molecular Docking
Open Access
- 8 May 2026
- journal article
- research article
- Published by MDPI AG in Antibiotics
- Vol. 15 (5) , 477
Abstract
Background/Objectives: Four novel thymol–benzimidazolium–chalcone hybrids were designed based on a molecular hybridization strategy that integrates bioactive scaffolds known for their antimicrobial and antioxidant properties. This approach aims to enhance biological activity through synergistic effects and multi-target interactions, as supported by previous studies on phenolic and benzimidazole derivatives. The inclusion of both antioxidant and antibacterial evaluations was motivated by the well-established role of oxidative stress in bacterial pathogenicity and resistance mechanisms. Methods: Their antibacterial potential was initially screened using the disk diffusion method and subsequently evaluated by determining MIC and MBC values against eight clinical Staphylococcus aureus isolates. Results: Among the tested compounds, compound 3a emerged as the most potent derivative, exhibiting MIC values ranging from 0.25 to 1 µg/mL. Morphological analysis confirmed significant disruption of bacterial cell integrity, and further investigation demonstrated strong antibiofilm activity accompanied by downregulation of key biofilm- and resistance-associated genes (icaA, dltB, and mepA). Molecular docking studies were performed against selected target proteins, including 1MWT, 3VSL, 3ZG5 (sortase A), and 2ZCS, which are associated with bacterial cell wall biosynthesis, DNA replication, virulence, and metabolic pathways. Compound 3a exhibited the highest binding affinity, with a docking score of −11.953 kcal/mol against 2ZCS. Conclusions: Overall, these findings highlight the potential of thymol-based benzimidazolium–chalcone hybrids as promising multifunctional agents with combined antibacterial, antibiofilm, and antioxidant properties.Keywords
This publication has 51 references indexed in Scilit:
- Novel triphenylphosphonium-hydrazone salts: integrated experimental and computational insights into AChE inhibition and resistance-overcoming antimicrobial and antibiofilm potentialNaunyn-Schmiedeberg's Archives of Pharmacology, 2026
- Unveiling the Multifaceted Bioactivities of Benzimidazolium Salts: Synthesis, Characterization, and Computational Insights Into AChE Inhibition and Antimicrobial Action Against Multidrug Resistance Bacteria MRSA and MDR E. coliChemistrySelect, 2025
- Synthesis and Characterization of Some New Hybrids of 2‐Chloroquinoline‐ Benzimidazole Chalcones as Potential Antibacterial AgentsChemistrySelect, 2025
- Chalcone derivatives disrupt cell membrane integrity of Saccharomyces cerevisiae cells and alter their biochemical compositionArchives of Microbiology, 2023
- Chalcones As Broad‐Spectrum Antimicrobial Agents: A Comprehensive Review And Analysis Of Their Antimicrobial ActivitiesChemistrySelect, 2023
- A New Discovery towards Novel Skeleton of Benzimidazole‐Conjugated Pyrimidinones as Unique Effective Antibacterial AgentsChinese Journal of Chemistry, 2022
- Benzimidazole Derivatives as Novel Zika Virus InhibitorsChemMedChem, 2020
- Chalcone synthesis, properties and medicinal applications: a reviewEnvironmental Chemistry Letters, 2020
- Systematic search for benzimidazole compounds and derivatives with antileishmanial effectsMolecular Diversity, 2018
- Naturally occurring chalcones and their biological activitiesPhytochemistry Reviews, 2014